The Library
Differential effects of RU486 reveal distinct mechanisms for glucocorticoid repression of prostaglandin E-2 release
Tools
UNSPECIFIED (2004) Differential effects of RU486 reveal distinct mechanisms for glucocorticoid repression of prostaglandin E-2 release. EUROPEAN JOURNAL OF BIOCHEMISTRY, 271 (20). pp. 4042-4052. doi:10.1111/j.1432-1033.2004.04342.x ISSN 0014-2956.
Research output not available from this repository.
Request-a-Copy directly from author or use local Library Get it For Me service.
Official URL: http://dx.doi.org/10.1111/j.1432-1033.2004.04342.x
Abstract
In A549 pulmonary cells, the dexamethasone- and budesonide-dependent repression of interleukin-1beta-induced prostaglandin E-2 release was mimicked by the steroid antagonist, RU486. Conversely, whereas dexamethasone and budesonide were highly effective inhibitors of interleukin-1beta-induced cyclooxygenase (COX)/prostaglandin E synthase (PGES) activity and COX-2 expression, RU486 (< 1 mum) was a poor inhibitor, but was able to efficiently antagonize the effects of dexamethasone and budesonide. In addition, both dexamethasone and RU486 repressed [H-3]arachidonate release, which is consistent with an effect at the level of phospholipase A(2) activity. By contrast, glucocorticoid response element-dependent transcription was unaffected by RU486 but induced by dexamethasone and budesonide, whilst dexamethasone- and budesonide-dependent repression of nuclear factor-kappaB-dependent transcription was maximally 30-40% and RU486 (< 1 mum) was without significant effect. Thus, two pharmacologically distinct mechanisms of glucocorticoid-dependent repression of prostaglandin E-2 release are revealed. First, glucocorticoid-dependent repression of arachidonic acid is mimicked by RU486 and, second, repression of COX/PGES is antagonized by RU486. Finally, whilst all compounds induced glucocorticoid receptor translocation, no role for glucocorticoid response element-dependent transcription is supported in these inhibitory processes and only a limited role for glucocorticoid-dependent inhibition of nuclear factor-kappaB in the repression of COX-2 is indicated.
Item Type: | Journal Article | ||||
---|---|---|---|---|---|
Subjects: | Q Science > QD Chemistry | ||||
Journal or Publication Title: | EUROPEAN JOURNAL OF BIOCHEMISTRY | ||||
Publisher: | BLACKWELL PUBLISHING LTD | ||||
ISSN: | 0014-2956 | ||||
Official Date: | October 2004 | ||||
Dates: |
|
||||
Volume: | 271 | ||||
Number: | 20 | ||||
Number of Pages: | 11 | ||||
Page Range: | pp. 4042-4052 | ||||
DOI: | 10.1111/j.1432-1033.2004.04342.x | ||||
Publication Status: | Published |
Data sourced from Thomson Reuters' Web of Knowledge
Request changes or add full text files to a record
Repository staff actions (login required)
View Item |